UnitedHealth Group Stock Outlook: Is Wall Street Bullish or Bearish?

UnitedHealth Group Stock Outlook: Is Wall Street Bullish or Bearish? Aritra Gangopadhyay Tue, August 11, 2026 at 11:54 AM GMT+2 2 min read UNH ^GSPC Logo of UNITEDHEALTH GROUP By Alexey Novikov Eden Prairie, Minnesota-based UnitedHealth Group Incorporated (UNH) operates as a health care company in the United States and internationally. The company is valued at $369.

7 billion and operates through four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. Shares of UnitedHealth have outpaced the broader market over the past year, surging 62. 9% compared to the S&P 500 Index's ($SPX) 21.

3% surge. Moreover, in 2026, the stock has risen by nearly 23. 8%, also rallying above SPX's 13.

3% gain. More News from Barchart Shaq Says His Dad Treated Him to White Castle, But When He Saw Homeless Man With a Sign, He Gave 3 of His Burgers to the Guy — 'Always Look Out for the Little Man' Micron vs. SK hynix: One Stock Rules AI Memory.

The Other Has More Room to Run. Rocket Lab Investors Have Plenty to Cheer Ahead of Q2 Earnings Today Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines.

Zooming in further, the State Street Healthcare Select Sector SPDR ETF (XLV) has risen 29. 4% over the past year, underperforming the stock. In 2026, XLV has surged 8.

8% and lagged behind the stock. www. barchart.

com On July 16, UNH stock rose 1. 2% following the release of its better-than-expected Q2 2026 earnings. The company's revenue for the quarter came in at $112.

03 billion and surpassed the Street's forecasts. Moreover, its adjusted EPS amounted to $6. 38, also topping Wall Street's estimates.

More impressively, the company's adjusted operating margin came in at 7. 1%, growing from 4. 6% in the previous year's quarter, showcasing greater efficiency in its operations.

UNH expects full-year earnings in the range of $19. 50 to $20 per share. For the current year, which ends in December, analysts expect UNH's EPS to rise 20.

4% to $19. 69 on a diluted basis. The company surpassed the consensus estimate in each of the last four quarters, which is impressive.

Among the 26 analysts covering UNH stock, the consensus is a "Strong Buy. " That's based on 20 "Strong Buy" ratings, three "Moderate Buys," and three "Holds. " www.

barchart. com The configuration has grown more bullish over the past months, with the stock now having 20 "Strong Buy" ratings, up from 18 three months prior. On July 22, Bernstein analyst Lance Wilkes maintained a "Buy" rating on UnitedHealth and set a price target of $512.

UNH's mean price target of $482 offers an upside of 17. 9% compared to the current market price. Its Street-high target of $529 implies a robust 29.

4% upside from current levels. On the date of publication, Aritra Gangopadhyay did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes.

This article was originally published on Barchart.